Heterologous expression and structural characterisation of a pyrazinone natural product assembly line.
Wyatt, M.A., Mok, M.C., Junop, M., Magarvey, N.A.(2012) Chembiochem 13: 2408-2415
- PubMed: 23070851 
- DOI: https://doi.org/10.1002/cbic.201200340
- Primary Citation of Related Structures:  
4F6C, 4F6L - PubMed Abstract: 
Through a number of strategies nonribosomal peptide assembly lines give rise to a metabolic diversity not possible by ribosomal synthesis. One distinction within nonribosomal assembly is that products are elaborated on an enzyme-tethered substrate, and their release is enzyme catalysed. Reductive release by NAD(P)H-dependent catalysts is one observed nonribosomal termination and release strategy. Here we probed the selectivity of a terminal reductase domain by using a full-length heterologously expressed nonribosomal peptide synthetase for the dipeptide aureusimine and were able to generate 17 new analogues. Further, we generated an X-ray structure of aureusimine terminal reductase to gain insight into the structural details associated with this enzymatic domain.
Organizational Affiliation: 
Michael G. Degroote Institute for Infectious Disease Research, McMaster University, 1200 Main St. W, Hamilton ON, L8N 3Z5, Canada.